A COVID treatment for vulnerable Americans isn’t getting to them
Share Now on:
Lack of outreach and unequal distribution has left millions without protection. Plus, how massive container ships have exacerbated supply chain woes.
Segments From this episode
For those who understand Fed lingo, the minutes can hint at divisions or disagreements, and where Fed policy may be headed.
Energy investors have profited as prices climbed. But companies hesitate to boost production, even though costs weigh on consumers.
Supply chain journalist Rachel Premack says megaships deserve some of the blame for shipping logjams and increased costs.
Scarcity and a lack of outreach has left millions of immunocompromised Americans without access to the treatment.
Overall, births are still trending downward.
“Sometimes my husband jokes that I’m running a gelato non-profit, and it certainly does feel that way,” said Uli Nasibova, owner of Uli’s Gelato.